Frontlight ResearchEarly access
CompletedNo phase
Association of Arterio-Venous Oxygen and Carbon Dioxide Gradients With Tissue Hypoperfusion and Mortality in Sepsis
Key facts
- Who runs it
- Gaziosmanpasa Research and Education Hospital
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 88 people enrolled
- Started
- 1 Mar 2025
- Ended
- 13 Jan 2026
- Type of study
- Observational
- Record updated
- 17 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Adult patients aged 18 years or older
- Diagnosis of sepsis
- Admission to the intensive care unit
- Intubated and receiving invasive mechanical ventilation
- Presence of a central venous catheter
Who cannot take part
- Patients receiving oxygen therapy via face mask or nasal cannula
- Patients treated with non-invasive mechanical ventilation
- Patients younger than 18 years
- Patients in whom a central venous catheter cannot be placed
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In patients with sepsis who are treated in the intensive care unit under invasive mechanical ventilation, the combined evaluation of ScvO₂ and PcvCO₂ may provide a comprehensive insight into tissue oxygenation and metabolic stress, allowing a more precise hemodynamic assessment in critically ill patients. The aim of this study is to evaluate the monitoring of ScvO₂, PcvCO₂, and EtCO₂ in intensive care patients in order to predict hemodynamic instability, 28-day mortality, and length of ICU stay, as well as to investigate their effects on cardiac output, tissue oxygenation, and hypoperfusion.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 17 July 2026